Eye Platform

ACCESS TO EYE PLATFORM (Microsoft Azure Platform)

 
 

KEY CONCEPTS

EYE PLATFORM ADDED VALUE

CLINICAL SITES – EVICR.net MEMBERS

EVICR.net

INDUSTRY AND OTHER NON-MEMBERS

EYE PLATFORM – SECURE AND TRUSTWORTHY

EYE PLATFORM – HOW IT WORKS

PROPOSE AN IMAGING STUDY

 

EYE PLATFORM – PILOT STUDY

INTERCEPT-AMD STUDY 

A collaborative resource of Heidelberg multimodal imaging of Intermediate AMD with and without early atrophy to study prediction of disease progression

SPONSOR

AIBILI, as Coordinating Centre of EVICR.net

COORDINATING INVESTIGATOR

Prof. Sobha Sivaprasad, MD, PhD – Moorfields Eye Hospital, London, UK (EVICR.net CS 10)

GRANT

Boehringer Ingelheim

 

KEY OBJECTIVES

PRIMARY OUTCOME MEASURE

Incidence of conversion to atrophy at two years.

Description: Number of patients who developed new or increasing atrophy.

CURRENT STATUS

Ongoing

HOW TO ACCESS THE EYE PLATFORM

If you already have credentials, you can immediately access the Eye Platform.

If you do not have yet credentials, please fill in the form below. As soon as validated you will then receive an e-mail with the credentials.